These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 582772)
21. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Saletu B; Grünberger J; Linzmayer L Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):362-73. PubMed ID: 3525428 [TBL] [Abstract][Full Text] [Related]
22. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Herrmann WM; Schärer E; Wendt G; Delini-Stula A Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498 [TBL] [Abstract][Full Text] [Related]
23. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine. Herrmann WM; Schärer E; Delini-Stula A Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485 [TBL] [Abstract][Full Text] [Related]
24. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364. Saletu B; Grünberger J; Cepko H Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736 [TBL] [Abstract][Full Text] [Related]
25. Effects of brotizolam on the sleep-waking cycle of the cat. Kuhn FJ Arzneimittelforschung; 1986 Mar; 36(3A):522-7. PubMed ID: 3718574 [TBL] [Abstract][Full Text] [Related]
26. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Saletu B; Grünberger J; Anderer P; Linzmayer L Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257 [TBL] [Abstract][Full Text] [Related]
27. Pharmacoelectroencephalographic study of brotizolam, a novel hypnotic. Fink M; Irwin P Clin Pharmacol Ther; 1981 Sep; 30(3):336-42. PubMed ID: 7273596 [TBL] [Abstract][Full Text] [Related]
28. Quantitative pharmaco-EEG and performance after administration of brotizolam to healthy volunteers. Saletu B; Grünberger J; Linzmayer L Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):333S-345S. PubMed ID: 6661379 [TBL] [Abstract][Full Text] [Related]
29. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers. Blin O; Micallef J; Audebert C; Legangneux E J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893 [TBL] [Abstract][Full Text] [Related]
30. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers]. Nobuhara K Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168 [TBL] [Abstract][Full Text] [Related]
31. Pharmaco-EEG profiles of typical and atypical antidepressants. Saletu B Adv Biochem Psychopharmacol; 1982; 32():257-68. PubMed ID: 7090895 [TBL] [Abstract][Full Text] [Related]
32. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test. Dement WC J Clin Psychiatry; 1991 Sep; 52 Suppl():31-7. PubMed ID: 1680123 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related]
34. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies. Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889 [TBL] [Abstract][Full Text] [Related]
35. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man. Saletu B; Grünberger J; Rajna P; Karobath M J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458 [TBL] [Abstract][Full Text] [Related]
36. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine]. Saletu B; Grünberger J; Anderer P; Chwatal K Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340 [TBL] [Abstract][Full Text] [Related]
37. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects. Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628 [TBL] [Abstract][Full Text] [Related]
38. The morning after: residual EEG effects of triazolam and flurazepam, alone and in combination with alcohol. Mendelson WB; Goodwin DW; Hill SY; Reichman JD Curr Ther Res Clin Exp; 1976 Feb; 19(2):155-63. PubMed ID: 2451 [No Abstract] [Full Text] [Related]
39. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings. Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150 [TBL] [Abstract][Full Text] [Related]
40. [Electroencephalographic assessment of dosage and sleep-profile in a hypnotic Triazolothienodiazepine (author's transl)]. Kubicki S EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1979 Jun; 10(2):95-100. PubMed ID: 225156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]